SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

CoreWeave Bond Yield Reaches 15.58% as Shares Hit 17-Month Low

CoreWeave’s 9.75% notes due October 2031 traded near 80.6 cents on the dollar Tuesday, lifting the yield to 15.58% from about 11.3% in mid-August. Shares fell 2.8% to $59.39 after touching $57.24, their lowest level since May 13, 2025.

CRWV

Story updates

02:58:40 PM UTC
SquawkNews
CoreWeave (CRWV) shares fell to their lowest level in 17 months in morning trade on Tuesday before reversing losses as the AI names came back under renewed selling pressure.John McPeake, an analyst at Rosenblatt Securities, told The Information that the company disclosed an additional 10% increase…

CoreWeave Inc. (NASDAQ: CRWV ) ‘s 9.75% notes due October 2031 traded near 80.6 cents on the dollar on Tuesday, pushing their yield to 15.58%, up from about 11.3% in mid-August. Shares were last down 2.8% at $59.39, slightly trimming losses after touching $57.24 intraday — their lowest level since May 13, 2025. CoreWeave’s stock price is now down 32% in a month, 17% this year and 57% from its June high of $138.25.

On Monday, Goldman Sachs analyst Gabriela Borges upgraded CoreWeave to Buy from Neutral while cutting her price target to $106 from $139, according to Analyst Ratings. Borges noted that CoreWeave raised computing prices by 25% in July and by another 10% in October. Goldman estimates the company’s average borrowing costs could rise by 100 to 200 basis points while returns on new projects stay attractive. HSBC disagrees.

On Monday, it kept a Reduce rating and a $39 target, estimating CoreWeave could generate about $12 million in annual revenue per megawatt in 2027, against $17 million to $18 million for larger cloud providers. Mizuho cut its target to $88 from $115 last week. Rothschild & Co started coverage in September with a Sell rating and a $54 target. The average analyst target is $135, more than double the share price.

Chart: CoreWeave’s 9.75% 10/31 yield to maturity Image: Envato Elements